StocksFundsScreenerSectorsWatchlists
CI

CI - Cigna Corp Stock Price, Fair Value and News

363.38USD+5.65 (+1.58%)Market Closed

Market Summary

CI
USD363.38+5.65
Market Closed
1.58%

CI Alerts

  • 3 major insider sales recently.

CI Stock Price

View Fullscreen

CI RSI Chart

CI Valuation

Market Cap

106.2B

Price/Earnings (Trailing)

19.78

Price/Sales (Trailing)

0.54

EV/EBITDA

12.81

Price/Free Cashflow

8.99

CI Price/Sales (Trailing)

CI Profitability

EBT Margin

2.82%

Return on Equity

11.62%

Return on Assets

3.52%

Free Cashflow Yield

11.12%

CI Fundamentals

CI Revenue

Revenue (TTM)

195.3B

Rev. Growth (Yr)

11.72%

Rev. Growth (Qtr)

4.21%

CI Earnings

Earnings (TTM)

5.4B

Earnings Growth (Yr)

-9.41%

Earnings Growth (Qtr)

-23.6%

Breaking Down CI Revenue

Last 7 days

-0.1%

Last 30 days

3.1%

Last 90 days

18.0%

Trailing 12 Months

30.6%

How does CI drawdown profile look like?

CI Financial Health

Current Ratio

0.77

Debt/Equity

0.61

Debt/Cashflow

0.42

CI Investor Care

Dividend Yield

1.35%

Dividend/Share (TTM)

4.92

Buy Backs (1Y)

1.58%

Diluted EPS (TTM)

17.4

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023183.0B186.1B189.9B195.3B
2022177.1B179.5B180.4B180.5B
2021162.9B166.8B170.1B174.1B
2020154.1B154.5B156.9B160.4B
201975.2B102.5B129.6B153.6B
201842.8B43.9B45.0B48.6B
201740.3B40.8B41.3B41.8B
201600039.8B

Tracking the Latest Insider Buys and Sells of Cigna Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 25, 2024
cordani david
acquired
4,344,920
139
31,209
chairman & ceo
Mar 25, 2024
cordani david
sold
-11,084,400
355
-31,209
chairman & ceo
Mar 22, 2024
cordani david
acquired
882,376
139
6,338
chairman & ceo
Mar 22, 2024
cordani david
sold
-2,250,680
355
-6,338
chairman & ceo
Mar 21, 2024
cordani david
acquired
319,231
139
2,293
chairman & ceo
Mar 21, 2024
cordani david
sold
-814,052
355
-2,293
chairman & ceo
Mar 14, 2024
cordani david
acquired
1,060,300
139
7,616
chairman & ceo
Mar 13, 2024
cordani david
acquired
1,915,810
139
13,761
chairman & ceo
Mar 13, 2024
cordani david
sold
-4,779,540
347
-13,761
chairman & ceo
Mar 12, 2024
cordani david
sold
-772,121
345
-2,238
chairman & ceo

1–10 of 50

Which funds bought or sold CI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 26, 2024
Fairman Group, LLC
new
-
10,481
10,481
0.01%
Mar 26, 2024
HighPoint Advisor Group LLC
new
-
2,046,000
2,046,000
0.15%
Mar 22, 2024
Livelsberger Financial Advisory
new
-
2,995
2,995
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-7.5
-3,869,920
118,061,000
0.09%
Mar 21, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
reduced
-35.29
-3,138,480
6,587,900
0.02%
Mar 18, 2024
CoreFirst Bank & Trust
reduced
-6.01
-10,747
655,796
0.44%
Mar 15, 2024
B. Riley Wealth Advisors, Inc.
reduced
-10.88
-140,135
1,949,500
0.05%
Mar 14, 2024
Leo Wealth, LLC
new
-
625,441
625,441
0.06%
Mar 14, 2024
ABLES, IANNONE, MOORE & ASSOCIATES, INC.
new
-
15,571
15,571
0.01%
Mar 13, 2024
MONECO Advisors, LLC
new
-
574,046
574,046
0.11%

1–10 of 46

Are Funds Buying or Selling CI?

Are funds buying CI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CI
No. of Funds

Unveiling Cigna Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
8.47%
24,775,082
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 25, 2024
blackrock inc.
8.4%
24,554,544
SC 13G/A
Feb 14, 2023
dodge & cox
3.8%
11,548,557
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
4.5%
13,656,608
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G
Feb 09, 2023
vanguard group inc
8.37%
25,583,766
SC 13G/A
Feb 07, 2023
blackrock inc.
9.0%
27,469,496
SC 13G
Feb 14, 2022
dodge & cox
5.3%
17,484,197
SC 13G
Feb 14, 2022
price t rowe associates inc /md/
5.4%
17,961,332
SC 13G/A

Recent SEC filings of Cigna Corp

View All Filings
Date Filed Form Type Document
Mar 25, 2024
144
Notice of Insider Sale Intent
Mar 25, 2024
4
Insider Trading
Mar 22, 2024
144
Notice of Insider Sale Intent
Mar 21, 2024
144
Notice of Insider Sale Intent
Mar 15, 2024
ARS
ARS
Mar 15, 2024
DEF 14A
DEF 14A
Mar 15, 2024
DEFA14A
DEFA14A
Mar 14, 2024
4
Insider Trading
Mar 13, 2024
144
Notice of Insider Sale Intent
Mar 12, 2024
144
Notice of Insider Sale Intent

What is the Fair Value of CI?

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Cheap
or
Expensive?


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks

Peers (Alternatives to Cigna Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
454.6B
371.6B
-6.04% 4.38%
20.31
1.22
14.64% 11.24%
106.2B
195.3B
3.13% 30.55%
19.78
0.54
8.17% -20.79%
100.0B
357.8B
1.79% 0.39%
11.97
0.28
10.95% 93.52%
87.7B
65.0B
6.93% 30.56%
16.74
1.35
7.86% -7.11%
41.9B
154.0B
-2.30% 15.93%
15.51
0.27
6.54% 124.79%
12.6B
14.3B
11.30% 47.77%
17.56
0.88
6.59% 6.24%
12.0B
12.1B
9.73% 82.98%
17.36
0.99
4.57% 23.40%
MID-CAP
9.7B
2.3B
11.19% 28.50%
35.74
4.3
6.06% 9.17%
7.2B
2.9B
-7.72% 12.77%
-333.68
2.47
12.20% -107.93%
2.3B
3.8B
3.63% -32.94%
11.05
0.61
-27.73% -52.50%
2.2B
1.4B
3.04% 7.42%
36.06
1.58
21.19% 34.42%
SMALL-CAP
1.7B
1.1B
9.76% -2.01%
26.93
1.59
11.31% 35.83%
1.2B
3.0B
4.38% 103.39%
-6.6
0.41
6.74% 20.73%
56.3M
-
28.14% -20.98%
-3.85
-
- -12.94%
16.9M
20.7M
-2.22% -14.90%
83.48
0.82
6.53% -85.60%

Cigna Corp News

Latest updates
Yahoo Finance UK • 17 hours ago
Defense World • 23 Mar 2024 • 09:39 am
Investing.com • 04 Mar 2024 • 08:00 am
Yahoo Finance • 29 Feb 2024 • 08:00 am
StreetInsider.com • 15 Feb 2024 • 11:02 am
PR Newswire • 15 Feb 2024 • 08:00 am
CNN • 3 months ago

Cigna Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue4.2%51,11449,04848,58646,51745,75345,28145,47844,00645,67944,28843,13140,97141,71240,95539,26538,46938,24538,55638,81937,94614,300
  S&GA Expenses7.2%4,0623,7883,4343,5383,4843,1513,2643,2753,6443,0932,9963,2793,9663,3013,4073,3983,9573,4133,3803,3033,480
EBITDA Margin-12.8%0.05*0.06*0.07*0.07*0.07*0.07*0.06*0.06*0.06*0.09*0.09*0.09*---------
Interest Expenses-19.6%311387310322306308307308303311308331327369348395388392488377100
Income Taxes-335.0%-9193913742951367134113551824244223421,23640652920827740934841681.00
Earnings Before Taxes-89.8%1881,8401,8841,6011,3583,4911,9811,5671,3202,0591,8981,5135,3781,8042,2891,3971,2611,7631,7581,788228
EBT Margin-19.8%0.03*0.04*0.04*0.05*0.05*0.05*0.04*0.04*0.04*0.06*0.06*0.07*---------
Net Income-23.6%1,1071,4491,5101,3061,2222,7781,5701,2121,1381,6351,4761,1714,1421,3981,7601,1899771,3541,4101,372144
Net Income Margin-4.8%0.03*0.03*0.04*0.04*0.04*0.04*0.03*0.03*0.03*0.05*0.05*0.05*---------
Free Cashflow-48.1%1,4672,8262,1824,7181,7892,9739341,7203,9651,809-606783---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets2.1%152,761149,645150,054147,976143,885144,209152,630152,610154,889154,251154,207152,081155,451160,044159,628154,711155,774154,847154,401154,348153,226
  Current Assets8.2%37,35134,51834,71132,02730,12230,17037,42235,39336,13425,48725,01125,55427,79934,55734,88030,87729,84521,16820,70921,13620,430
    Cash Equivalents-7.9%7,8228,4979,5857,9355,9247,1174,4684,4695,1233,5403,8786,5444,1575,4067,1854,452-4,5773,6104,976243
  Inventory27.8%5,6454,4164,5144,2114,7774,0173,7813,5003,7223,0203,0422,9193,1652,6572,7122,5652,6612,1602,2982,3822,821
  Net PPE-----------------4,4174,4484,5384,5234,562
  Goodwill-3.4%44,25945,81045,81145,81145,81145,80745,81045,80445,81146,05646,06344,63544,64844,68544,59044,58444,60244,46244,44944,53744,505
Liabilities2.4%106,410103,879104,528103,38099,13199,076106,663106,446107,705106,768105,440103,867105,065111,946112,223109,590110,395110,114110,552111,897112,154
  Current Liabilities3.5%48,71647,05947,34544,72741,22541,11545,21843,66243,57236,34034,71133,47036,02243,88642,17940,38040,13834,44731,86732,96931,895
  Long Term Debt0.2%28,15528,09428,11529,12428,10028,09030,98431,01331,12531,60931,60631,56829,54529,53731,77432,14731,89334,04136,88537,57139,523
Shareholder's Equity1.2%46,22345,69145,46444,51844,67544,80645,70146,14546,97647,42748,71648,15550,18948,03947,37145,08645,34444,69943,81842,41341,035
  Retained Earnings1.6%41,65240,98239,93638,84137,94037,04134,62633,42032,59331,80330,51329,38928,57524,44023,05221,29820,16219,18517,83416,42615,088
  Additional Paid-In Capital0.3%30,66930,56330,43630,33230,23329,39529,93029,73629,57429,07729,40329,25428,97528,77728,69928,55428,30628,11527,89127,85527,751
Shares Outstanding-----------------372373378379-
Minority Interest90.9%21.0011.0019.0016.0013.0042.0030.0022.0018.0012.007.006.007.007.005.007.006.003.003.005.007.00
Float---82,800---82,800---80,800---68,900---59,400--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-48.1%1,4672,8262,4925,0282,0993,2831,2442,0304,2752,119-2961,0934,2948953,2741,8872,7932,4611,0393,192126
Cashflow From Investing67.1%-440-1,337-414-2,983-6164,446-408-324123-710-2,307-7174,420-938-237-269-271-304-634475-24,704
Cashflow From Financing51.4%-1,250-2,572-435-37.00-2,636-5,517-916-2,171-2,371-1,728-62.00-4,051-4,721-1,682-312-1,818-1,707-1,173-1,773-2,5344,400
  Dividend Payments-1.1%358362362368334341352357324330342345--15.00------
  Buy Backs-12.8%5446241549621,7333,5001,0061,3681,4212,6119162,7941,6901,02836895644767440446232.00

CI Income Statement

2023-12-31
Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
[1]
Dec. 31, 2021
[1]
Revenues   
Premiums$ 44,237$ 39,916$ 41,154
Net investment income1,1661,1551,549
TOTAL REVENUES195,265180,518174,069
Benefits and expenses   
Pharmacy and other service costs133,801124,834117,553
Medical costs and other benefit expenses36,28732,18433,565
Selling, general and administrative expenses14,82213,17413,012
Amortization of acquired intangible assets1,8191,8761,998
TOTAL BENEFITS AND EXPENSES186,729172,068166,128
Income from operations8,5368,4507,941
Interest expense and other(1,446)(1,228)(1,208)
Debt extinguishment costs00(141)
(Loss) gain on sale of businesses(1,499)1,6620
Net realized investment (losses) gains(78)(487)198
Income before income taxes5,5138,3976,790
TOTAL INCOME TAXES1411,6151,370
Net income5,3726,7825,420
Less: Net income attributable to noncontrolling interests2087850
SHAREHOLDERS' NET INCOME$ 5,164$ 6,704$ 5,370
Shareholders' net income per share   
Basic (in dollars per share)$ 17.57$ 21.66$ 15.89
Diluted (in dollars per share)$ 17.39$ 21.41$ 15.75
Pharmacy revenues   
Revenues   
Revenues$ 137,243$ 128,566$ 121,413
Fees and other revenues   
Revenues   
Revenues$ 12,619$ 10,881$ 9,953
[1]Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.

CI Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
[1]
Assets  
Cash and cash equivalents$ 7,822$ 5,924
Investments925905
Accounts receivable, net17,72217,218
Inventories5,6454,777
Other current assets2,1691,298
Assets of businesses held for sale3,0680
Total current assets37,35130,122
Long-term investments17,98516,288
Reinsurance recoverables4,8355,416
Property and equipment3,6953,774
Goodwill44,25945,811
Other intangible assets30,86332,492
Other assets3,4212,704
Separate account assets7,4307,278
Assets of businesses held for sale, non-current2,9220
TOTAL ASSETS152,761143,885
Liabilities  
Current insurance and contractholder liabilities5,5145,409
Pharmacy and other service costs payable19,81517,070
Accounts payable8,5537,775
Accrued expenses and other liabilities9,9557,978
Short-term debt2,7752,993
Liabilities of businesses held for sale2,1040
Total current liabilities48,71641,225
Non-current insurance and contractholder liabilities10,90411,976
Deferred tax liabilities, net7,1737,786
Other non-current liabilities3,4412,766
Long-term debt28,15528,100
Separate account liabilities7,4307,278
Liabilities of businesses held for sale, non-current5910
TOTAL LIABILITIES106,41099,131
Contingencies — Note 24
Redeemable noncontrolling interests10766
Shareholders' equity  
Common stock[2]44
Additional paid-in capital30,66930,233
Accumulated other comprehensive loss(1,864)(1,658)
Retained earnings41,65237,940
Less: Treasury stock, at cost(24,238)(21,844)
TOTAL SHAREHOLDERS' EQUITY46,22344,675
Other noncontrolling interests2113
Total equity46,24444,688
Total liabilities and equity$ 152,761$ 143,885
[1]Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.
[2]Par value per share, $0.01; shares issued, 400 million as of December 31, 2023 and 398 million as of December 31, 2022; authorized shares, 600 million.
CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
 CEO
 WEBSITEwww.cigna.com
 EMPLOYEES65535

Cigna Corp Frequently Asked Questions


What is the ticker symbol for Cigna Corp? What does CI stand for in stocks?

CI is the stock ticker symbol of Cigna Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cigna Corp (CI)?

As of Wed Mar 27 2024, market cap of Cigna Corp is 106.24 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CI stock?

You can check CI's fair value in chart for subscribers.

What is the fair value of CI stock?

You can check CI's fair value in chart for subscribers. The fair value of Cigna Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cigna Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cigna Corp a good stock to buy?

The fair value guage provides a quick view whether CI is over valued or under valued. Whether Cigna Corp is cheap or expensive depends on the assumptions which impact Cigna Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CI.

What is Cigna Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, CI's PE ratio (Price to Earnings) is 19.78 and Price to Sales (PS) ratio is 0.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cigna Corp's stock?

In the past 10 years, Cigna Corp has provided 0.161 (multiply by 100 for percentage) rate of return.